drugset / Trial / NCT07599046

Fecal Microbiota Transplantation (FMT) Combined With Calorie-Restricted Diet and Semaglutide in Patients With Obesity and Type 2 Diabetes

NCT07599046

RandomizedParallel-groupOpen-labelTreatment

Summary

Investigation of the efficacy of fecal microbiota transplantation added to calorie-restricted diet and semaglutide versus calorie-restricted diet and semaglutide alone for weight loss and metabolic improvement in patients with moderate to severe obesity and type 2 diabetes mellitus.

Timeline

Start
2026-04-30
Primary completion
2027-01-30
Completion
2029-12-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Ornidazole Other / unclassified 10 unknown Oral
Subject Semaglutide Peptide 1 mg Subcutaneous